Skipping the line

Bringing MET exon 14 skipping mutations to the forefront of targeted therapy

Elaine Shum, Balazs Halmos

Research output: Contribution to journalEditorial

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)110-116
Number of pages7
JournalTranslational Cancer Research
Volume5
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Exons
Mutation
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Skipping the line : Bringing MET exon 14 skipping mutations to the forefront of targeted therapy. / Shum, Elaine; Halmos, Balazs.

In: Translational Cancer Research, Vol. 5, No. 2, 01.04.2016, p. 110-116.

Research output: Contribution to journalEditorial

@article{9fa00698671f400cb868eee1dc749d74,
title = "Skipping the line: Bringing MET exon 14 skipping mutations to the forefront of targeted therapy",
author = "Elaine Shum and Balazs Halmos",
year = "2016",
month = "4",
day = "1",
doi = "10.21037/tcr.2016.03.12",
language = "English (US)",
volume = "5",
pages = "110--116",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",
number = "2",

}

TY - JOUR

T1 - Skipping the line

T2 - Bringing MET exon 14 skipping mutations to the forefront of targeted therapy

AU - Shum, Elaine

AU - Halmos, Balazs

PY - 2016/4/1

Y1 - 2016/4/1

UR - http://www.scopus.com/inward/record.url?scp=84966290810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966290810&partnerID=8YFLogxK

U2 - 10.21037/tcr.2016.03.12

DO - 10.21037/tcr.2016.03.12

M3 - Editorial

VL - 5

SP - 110

EP - 116

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

IS - 2

ER -